Company Active LTD

Company profile

Neumind Ltd

neumind: Helping Digitise Neurorehabilitation.

Millions of people live with or care for someone with neurological conditions such as stroke, brain injury or dementia. We are here to help.

CRN

12044517

Founded

2019

Age

Overview

Legal name

NEUMIND LTD

Region

East of England

Registered address

39 LEEWAY AVENUE

GREAT SHELFORD

CAMBRIDGE

UNITED KINGDOM

CB22 5AU

Insolvency history

Latest accounts

Financial period: 1 Jul 2023 to 30 Jun 2024

FILLETEDACCOUNTS

Turnover

Unknown

Profit / Loss

Unknown

Employees

Company events

Reference milestones and recent Companies House filing stream events.

6 events

31 Mar

2027

Accounts due

Accounts Due

Next accounts due date

12 Dec

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

28 Nov

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun

2025

Accounts filed

Accounts

Last accounts made up date

02 Oct

2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzODEyOTM2NmFkaXF6a2N4

Published 02 Oct 2024 11:07

11 Jun

2019

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2022

Funded years

2022

Age at first award

2 years

Projects

2022 Grant for R&D Lead participant

A next-generation support system and personalised therapy platform for individuals with neurological conditions, as well as their family/caregivers.

1 Nov 2022 to 30 Apr 2023

Awarded

£49,533

Total cost £49,533

Rehabilitation for individuals who have suffered a brain injury, stroke, and other similar neurological conditions is stuck in a decades-long rut. Among experts, it has long been agreed that the NHS does not satisfy the demand, and the gap between acceptable and available service is worsening. Private services and sectors such as medico-legal and medical-...

2022 Collaborative R&D Lead participant

A next-generation cognitive orthotic and neurorehabilitation platform to transform healthcare for those with neurological conditions.

1 Mar 2022 to 28 Feb 2023

Awarded

£50,000

Total cost £50,000

Product types

Collaborative R&D Grant for R&D